Exchange: NASDAQ·Updated 02:25 PM EDT
News
all
press releases
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Harvard Bioscience Q1 2026 Earnings Call Transcript
read more...
Benzinga
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Purchases 8,475 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 8,475 shares of the stock in a transaction dated Tuesday, March 17th. The shares were bought at an average...
MarketBeat
Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director Stephen Denelsky acquired 10,000 shares of Harvard Bioscience stock in a transaction that occurred on Tuesday, March 17th. The shares...
MarketBeat
Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 12,525 shares of the stock in a transaction dated Monday, March 16th. The stock was acquired at an average...
MarketBeat
Insider Buying: Harvard Bioscience (NASDAQ:HBIO) Director Purchases 8,475 Shares of Stock
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider bought 8,475 shares of the stock in a transaction on Tuesday, March 17th. The stock was purchased at an average price...
MarketBeat
John Duke Purchases 5,000 Shares of Harvard Bioscience (NASDAQ:HBIO) Stock
Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) CEO John Duke bought 5,000 shares of the firm's stock in a transaction on Monday, March 16th. The shares were acquired at an average price of...
MarketBeat

Advertisement|Remove ads.